By: IPP Bureau
Last updated : February 08, 2022 7:48 pm
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ comparison
The company has reported a total income of Rs. 456.2704 crore during the period ended December 31, 2021 as compared to Rs. 306.0294 crore during the period ended September 30, 2021.
The company has posted a net profit of Rs. 160.0690 crore for the period ended December 31, 2021 as against a net profit of Rs. 96.9848 crore for the period ended September 30, 2021.
Financial Results (Q3 FY2022) - YoY comparison
The company has reported a total income of Rs. 456.2704 crore during the period ended December 31, 2021 as compared to Rs.279.7761 crore during the period ended December 31, 2020.
The company has posted a net profit of Rs.160.0690 crore for the period ended December 31, 2021 as against a net profit of Rs.113.6253 crore for the period ended December 31, 2020.
Financial Results (nine-month ended FY2022) - YoY comparison
The company has reported total income of Rs.1031.8840 crore during the nine-month period ended December 31, 2021 as compared to Rs.761.4925 crore during the nine-month period ended December 31, 2020.
The company has posted a net profit of Rs.362.1369 crore for the nine-month period ended December 31, 2021 as against a net profit of Rs.279.2259 crore for the nine-month period ended December 31, 2020.